HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George Fountzilas Selected Research

Adjuvant Chemotherapy

1/2022Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients.
1/2019Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome.
1/2019Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer.
11/2018Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer.
10/2018Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy.
1/2018Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population.
1/2018Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.
8/2017Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy.
5/2017Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.
2/2017What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George Fountzilas Research Topics

Disease

133Neoplasms (Cancer)
10/2022 - 04/2003
91Breast Neoplasms (Breast Cancer)
10/2022 - 06/2003
26Carcinoma (Carcinomatosis)
01/2022 - 08/2002
26Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2005
17Neoplasm Metastasis (Metastasis)
01/2021 - 07/2005
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 09/2002
12Disease Progression
03/2020 - 06/2003
11Head and Neck Neoplasms (Head and Neck Cancer)
03/2021 - 05/2003
9Nasopharyngeal Carcinoma
01/2022 - 04/2005
8Squamous Cell Carcinoma of Head and Neck
12/2019 - 01/2005
8Melanoma (Melanoma, Malignant)
01/2016 - 04/2003
7Stomach Neoplasms (Stomach Cancer)
06/2021 - 10/2004
7Adenocarcinoma
06/2021 - 01/2005
7Ovarian Neoplasms (Ovarian Cancer)
12/2019 - 01/2004
7Colonic Neoplasms (Colon Cancer)
12/2019 - 08/2002
7Glioblastoma (Glioblastoma Multiforme)
01/2019 - 11/2006
5Febrile Neutropenia
07/2015 - 06/2004
5Ovarian Epithelial Carcinoma
03/2007 - 01/2004
4Triple Negative Breast Neoplasms
03/2021 - 01/2016
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 10/2008
4Endometrial Neoplasms (Endometrial Cancer)
01/2019 - 07/2008
4Neutropenia
07/2015 - 08/2002
4Laryngeal Neoplasms (Laryngeal Cancer)
11/2014 - 11/2005
3Renal Cell Carcinoma (Grawitz Tumor)
04/2019 - 09/2009
3Glioma (Gliomas)
09/2018 - 04/2013
3Brain Neoplasms (Brain Tumor)
09/2017 - 09/2005
3Infections
09/2017 - 01/2003

Drug/Important Bio-Agent (IBA)

45ParaffinIBA
11/2021 - 11/2005
39Proteins (Proteins, Gene)FDA Link
10/2022 - 01/2007
34Messenger RNA (mRNA)IBA
01/2022 - 01/2005
34Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2005
31Formaldehyde (Formol)FDA Link
03/2021 - 08/2008
31Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 09/2002
23Trastuzumab (Herceptin)FDA Link
10/2022 - 06/2003
20ErbB Receptors (EGF Receptor)IBA
01/2022 - 07/2005
18AnthracyclinesIBA
01/2022 - 01/2004
18Fluorouracil (Carac)FDA LinkGeneric
06/2021 - 08/2002
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021 - 03/2005
16Carboplatin (JM8)FDA LinkGeneric
10/2016 - 09/2002
15Docetaxel (Taxotere)FDA Link
01/2018 - 07/2003
14Epirubicin (Ellence)FDA LinkGeneric
01/2020 - 04/2005
13GemcitabineFDA Link
02/2020 - 09/2002
11Leucovorin (Folinic Acid)FDA Link
12/2019 - 08/2002
11Irinotecan (Camptosar)FDA LinkGeneric
12/2019 - 07/2005
11Estrogen ReceptorsIBA
01/2018 - 07/2009
10human ERBB2 proteinIBA
10/2022 - 06/2012
10Cisplatin (Platino)FDA LinkGeneric
06/2021 - 05/2003
10PlatinumIBA
04/2020 - 01/2004
10Monoclonal AntibodiesIBA
11/2018 - 08/2002
9Taxoids (Taxanes)IBA
01/2022 - 07/2003
9DNA (Deoxyribonucleic Acid)IBA
02/2021 - 02/2006
9Bevacizumab (Avastin)FDA Link
04/2020 - 02/2010
9Hormones (Hormone)IBA
01/2020 - 06/2006
9Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2019 - 01/2005
9Progesterone Receptors (Progesterone Receptor)IBA
01/2017 - 07/2009
9Cetuximab (Erbitux)FDA Link
06/2015 - 08/2008
8taxaneIBA
01/2020 - 01/2004
8Phenobarbital (Luminal)FDA Link
01/2017 - 02/2013
7Capecitabine (Xeloda)FDA Link
05/2018 - 01/2005
7Vinorelbine (Navelbine)FDA LinkGeneric
01/2018 - 12/2003
7Vascular Endothelial Growth Factor CIBA
01/2018 - 11/2006
7RNA (Ribonucleic Acid)IBA
07/2015 - 11/2006
6LigandsIBA
01/2022 - 06/2012
6thiamine triphosphorate (TTP)IBA
01/2022 - 01/2005
6Epidermal Growth Factor (EGF)IBA
01/2021 - 07/2007
6Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 01/2006
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 02/2004
6Cyclin D1IBA
01/2019 - 01/2013
6Temozolomide (Temodar)FDA LinkGeneric
01/2019 - 11/2006
6Cadherins (E-Cadherin)IBA
05/2016 - 07/2007
5Tyrosine Kinase InhibitorsIBA
01/2021 - 07/2005
5PTEN Phosphohydrolase (PTEN Phosphatase)IBA
05/2020 - 05/2014
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2010 - 07/2005
5liposomal doxorubicin (Doxil)FDA Link
01/2010 - 06/2004
4CateninsIBA
01/2018 - 10/2013
4InterferonsIBA
01/2016 - 02/2006
4Thymidylate SynthaseIBA
09/2014 - 07/2007
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2013 - 01/2007
4Sunitinib (Sutent)FDA Link
08/2013 - 09/2009
4Gefitinib (Iressa)FDA Link
01/2010 - 07/2005
3Protein Isoforms (Isoforms)IBA
04/2021 - 10/2014
3Androgen Receptors (Androgen Receptor)IBA
03/2021 - 06/2014
3Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020 - 01/2006
3ChemokinesIBA
01/2020 - 06/2012
3TOR Serine-Threonine KinasesIBA
04/2019 - 07/2014
3Somatomedin Receptors (Somatomedin Receptor)IBA
11/2018 - 01/2013
3Growth Factor ReceptorsIBA
12/2016 - 11/2007
3XELOXIBA
01/2016 - 01/2005
3Type I DNA Topoisomerases (Topoisomerase I)IBA
09/2014 - 07/2007
3Interferon alpha-2 (Roferon-A)FDA Link
02/2009 - 05/2004

Therapy/Procedure

81Drug Therapy (Chemotherapy)
01/2022 - 08/2002
39Therapeutics
01/2022 - 09/2003
36Adjuvant Chemotherapy
01/2022 - 01/2005
18Radiotherapy
01/2022 - 05/2003
7Chemoradiotherapy
04/2013 - 01/2004
5Immunotherapy
01/2022 - 02/2006
4Induction Chemotherapy
02/2017 - 04/2005
3Semiconductors
05/2016 - 01/2015
3Treatment Delay
07/2015 - 01/2009
3Brachytherapy
01/2011 - 02/2007